| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1616340-68-1 | 5-[[[(2,4-Difluorophenyl)methyl]amino]carbonyl]-1-(2,2-dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo-2-pyridinecarboxylic acid methyl ester | C20H22F2N2O7 |
| 1616340-94-3 | (2R,5S,13aR)-2,3,4,5,7,9,13,13a-Octahydro-8-methoxy-7,9-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide | C22H20F3N3O5 |
| 1616342-45-0 | (2R,5S,13aR)-2,3,4,5,7,9,13,13a-Octahydro-8-methoxy-7,9-dioxo-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid | C15H16N2O6 |
| 1616391-65-1 | N-[(2S)-3-(3,4-Dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl]-6-(3-oxetanylamino)-4-pyrimidinecarboxamide | C20H25N5O3 |
| 1616391-87-7 | 2-(Cyclobutylamino)-N-[(2S)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl]-4-pyridinecarboxamide | C22H28N4O2 |
| 1616392-22-3 | GSK3326595 | C24H32N6O3 |
| 1616493-44-7 | Tucidinostat | C22H19FN4O2 |
| 1616499-37-6 | 2-(2-Chloroquinazolin-4-yl)-9-phenyl-9H-carbazole | C26H16ClN3 |
| 1616592-59-6 | Erythrinin D | C21H18O6 |
| 1616592-60-9 | Erythrinin F | C20H18O7 |
| 1616592-61-0 | Erythrinin G | C20H18O6 |
| 1616592-62-1 | Erythrinin H | C17H12O7 |
| 1616607-88-5 | 2-(2-Bromophenyl)-9-phenyl-9H-carbazole | C24H16BrN |
| 1616632-77-9 | 2,4,6,7,8,9-Hexahydro-4-[(2-methylphenyl)methyl]-7-(phenylmethyl)imidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one | C24H26N4O |
| 1616668-55-3 | Tetrazine-NHS Ester | C14H11N5O4 |
| 1616683-51-2 | Dodovisone B | C27H32O9 |
| 1616683-55-6 | Dodovislactone B | C21H30O5 |
| 1616703-93-5 | Ticagrelor EP Impurity C | C25H30F2N6O5S |
| 1616710-50-9 | Ivabradine Impurity 15 | C27H35ClN2O6 |
| 1616757-59-5 | Caesalpine A | C23H32O7 |
| 1616757-60-8 | Caesalpine B | C23H30O7 |
| 1616760-97-4 | 2-Chloro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine | C13H18ClN5 |
| 1616761-00-2 | (3R,4R)-3-[(2-Chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-beta-oxo-1-piperidinepropanenitrile | C16H19ClN6O |
| 1616761-01-3 | (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanoic acid methyl ester | C17H23N5O3 |
| 1616967-26-0 | Formoterol EP Impurity E | C20H26N2O4 |
| 1616979-93-1 | tert-Butylbis(3,5-di-tert-butylphenyl)phosphine | C32H51P |
| 1616983-07-3 | 4,6-Dibromobenzene-1,2,3,5-d4 | C6D4Br2 |
| 1618083-32-1 | 3-Amino-4-(aminomethyl)benzoic acid methyl ester | C9H12N2O2 |
| 1618107-00-8 | 2-Chloro-4-(2-dibenzofuranyl)-6-phenyl-1,3,5-triazine | C21H12ClN3O |
| 1618657-31-0 | Ezetimibe Impurity 9 | C18H17FO4 |
| 1619903-54-6 | LY2857785 | C26H36N6O |
| 1619934-76-7 | Ethyl 1-(4-methoxyphenyl)-7a-morpholino-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-3a,4,5,6,7,7a-hexahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | C31H37N5O6 |
| 1619967-09-7 | (3,3'-Difluoro-[2,2'-bithiophene]-5,5'-diyl)bis(trimethylstannane) | C14H20F2S2Sn2 |
| 1619994-68-1 | 1-[1-[2-(Methylsulfonyl)phenyl]-7-propoxy-3-indolizinyl]ethanone | C20H21NO4S |
| 1619994-69-2 | Ethyl (3-methyl-6-(4-methyl-3-(methylsulfonamido)phenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-yl)carbamate | C17H20N6O4S |
| 1620056-83-8 | 2-(5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetic acid | C10H7F5N2O2 |
| 1620097-04-2 | N-[(3R)-3-[[(1,1-Dimethylethoxy)carbonyl]amino]-1-oxobutyl]-N-(phenylmethyl)glycine methyl ester | C19H28N2O5 |
| 1620097-05-3 | (7R)-Tetrahydro-7-methyl-4-(phenylmethyl)-1H-1,4-diazepine-2,5-dione | C13H16N2O2 |
| 1620097-06-4 | (5R)-Hexahydro-5-methyl-1-(phenylmethyl)-1H-1,4-diazepine | C13H20N2 |
| 1620097-07-5 | [(7R)-Hexahydro-7-methyl-4-(phenylmethyl)-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone | C23H27N5O |
| 1620146-04-4 | 2-(Acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→4)-O-[2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→2)]-O-beta-D-mannopyranosyl-(1→4)-O-[O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→4)-O-[O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→2)]-O-alpha-D-mannopyranosyl-(1→3)]-O-alpha-D-mannopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→4)-D-mannose | C66H110N6O46 |
| 1620222-02-7 | 2,3:5,6-Bis-O-(1-methylethylidene)-D-myo-inositol 1,4-dibutanoate | C20H32O8 |
| 1620278-72-9 | TLR7/8 agonist 1 dihydrochloride | C22H27Cl2N5 |
| 1620389-14-1 | L-Phenylalanyl-L-leucyl-L-leucylglycyl-L-leucyl-L-isoleucyl-L-phenylalanyl-L-leucyl-L-leucine | C56H89N9O10 |
| 1620401-82-2 | 6,7-Dimethoxy-2-(1-pyrrolidinyl)-N-[5-(1-pyrrolidinyl)pentyl]-4-quinazolinamine | C23H35N5O2 |
| 1620401-83-3 | UNC0379 trifluoroacetate | C25H36F3N5O4 |
| 1620410-09-4 | Pyrazine-2,3-diyldimethanethiol | C6H8N2S2 |
| 1620458-09-4 | Zoliflodacin | C22H22FN5O7 |
| 1620576-64-8 | 1-[4-[5-[5-Amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-1-ethyl-1H-1,2,4-triazol-3-yl]piperidin-1-yl]-3-hydroxypropan-1-one | C22H31N9O3 |
| 1620758-21-5 | Empagliflozin Impurity 6 | C32H37ClO12 |